Fingerprint
Dive into the research topics of 'Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer
Walter M. Stadler*, Timothy Kuzel, Bruce Roth, Derek Raghavan, F. Andrew Dorr
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
316
Scopus
citations